Clinical trial
Comparative Study Between Hydroxyapetite Nanoparticles and Tricalcium Phosphate Nanoparticles Loaded on Platelet Rich Fibrin Membranes for Treatment of Gingival Recession
NCT07088809 is registered in ClinicalTrials.gov with Enas Elgendy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study Between Hydroxyapetite Nanoparticles and Tricalcium Phosphate Nanoparticles Loaded on Platelet Rich Fibrin Membranes for Treatment of Gingival Recession
- Lead sponsor
- Enas Elgendy
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- October 1, 2024
- Completion date
- September 1, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gingival recession localized moderate, nano tricalcium phosphate, nano-hydroxyapatite, periodontal diseases, platelet rich fibrin